Works matching DE "DRUG resistance in cancer cells"


Results: 5000
    1
    2
    3
    4
    5
    6

    Phase I clinical trial combining imatinib mesylate and IL-2 in refractory cancer patients: IL-2 interferes with the pharmacokinetics of imatinib mesylate.

    Published in:
    OncoImmunology, 2013, v. 2, n. 2, p. e23079-1, doi. 10.4161/onci.23079
    By:
    • Pautier, Patricia;
    • Locher, Clara;
    • Robert, Caroline;
    • Deroussent, Alain;
    • Flament, Caroline;
    • Le Cesne, Axel;
    • Rey, Annie;
    • Bahleda, Ratislav;
    • Ribrag, Vincent;
    • Soria, Jean-Charles;
    • Vassal, Gilles;
    • Eggermont, Alexander;
    • Zitvogel, Laurence;
    • Chaput, Nathalie;
    • Paci, Angelo
    Publication type:
    Article
    7
    8
    9
    10
    11
    12
    13
    14

    Cystathionine gamma‐lyase‐mediated hypoxia inducible factor 1‐alpha expression drives clear cell ovarian cancer progression.

    Published in:
    Journal of Pathology, 2025, v. 266, n. 3, p. 352, doi. 10.1002/path.6433
    By:
    • EL‐Naggar, Amal M;
    • Li, Yuqin;
    • Turgu, Busra;
    • Ding, Yuchen;
    • Wei, Longyijie;
    • Chen, Shary Yuting;
    • Trigo‐Gonzalez, Genny;
    • Kalantari, Forouh;
    • Vallejos, Rodrigo;
    • Lynch, Branden;
    • Senz, Janine;
    • Lum, Amy;
    • Douglas, J Maxwell;
    • Salamanca, Clara;
    • Thornton, Shelby;
    • Qin, Yimei;
    • Parmar, Kiran;
    • Spencer, Sandra E;
    • Leung, Samuel;
    • Woo, Michelle M M
    Publication type:
    Article
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28

    Phase Ia/Ib Study of Afatinib with Capecitabine in Patients with Refractory Solid Tumors and Pancreaticobiliary Cancers.

    Published in:
    Cancers, 2025, v. 17, n. 11, p. 1830, doi. 10.3390/cancers17111830
    By:
    • King, Gentry G.;
    • Baker, Kelsey K.;
    • Coveler, Andrew L.;
    • Harris, William P.;
    • Cohen, Stacey A.;
    • Shankaran, Veena;
    • Zhen, David B.;
    • Safyan, Rachael A.;
    • Lee, Hannah H.;
    • Alidina, Annie;
    • Hensel, Jeniece;
    • Hibbert, Reina;
    • Durm, Greg A.;
    • LaFary, Yvonne C.;
    • Younger, Anne;
    • Kugel, Sita;
    • Collisson, Eric;
    • Konnick, Eric Q.;
    • Redman, Mary W.;
    • Schneider, Bryan P.
    Publication type:
    Article
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43

    Research progress of galectins in glioma.

    Published in:
    Discover Oncology, 2025, v. 16, n. 1, p. 1, doi. 10.1007/s12672-025-02318-4
    By:
    • Feng, Xin-Li;
    • Su, Gang;
    • Wu, Qiong-Hui;
    • Jia, Qi;
    • Zhang, Zhen-Chang
    Publication type:
    Article
    44

    Mechanism and application of lactylation in cancers.

    Published in:
    Cell & Bioscience, 2025, v. 15, n. 1, p. 1, doi. 10.1186/s13578-025-01415-9
    By:
    • Wang, Jiewen;
    • Peng, Mingjing;
    • Oyang, Linda;
    • Shen, Mengzhou;
    • Li, Shizhen;
    • Jiang, Xianjie;
    • Ren, Zongyao;
    • Peng, Qiu;
    • Xu, Xuemeng;
    • Tan, Shiming;
    • Xia, Longzheng;
    • Yang, Wenjuan;
    • Li, Haofan;
    • Wu, Nayiyuan;
    • Tang, Yanyan;
    • Lin, Jinguan;
    • Liao, Qianjin;
    • Han, Yaqian;
    • Zhou, Yujuan
    Publication type:
    Article
    45
    46

    IGF2BP3在肝癌中的研究进展.

    Published in:
    Journal of Modern Medicine & Health, 2025, v. 41, n. 5, p. 1214, doi. 10.3969/j.issn.1009-5519.2025.05.034
    By:
    • 杨宛林;
    • 叶宇璐;
    • 宁登冲;
    • 叶 霞;
    • 蓝金艳;
    • 易廷庄
    Publication type:
    Article
    47
    48
    49
    50